Safety and Efficacy Study of Intravenous Lidocaine After Colorectal Surgery: LIDOREHAB
Colorectal Neoplasms
About this trial
This is an interventional treatment trial for Colorectal Neoplasms focused on measuring Double blind method, Prospective study, Lidocaine/administration and dosage/therapeutic use, Anaesthetics local/administration and dosage, Opioids/administration and dosage, Pain, postoperative, Perioperative care, Postoperative care, Analgesia, Patient-controlled, Length of stay, Survival analysis, Patient satisfaction, Surgery, Middle age, Adult, Aged
Eligibility Criteria
Inclusion Criteria: Colorectal neoplasm Radical surgery Median incision Exclusion Criteria: American Society of Anesthesiologists (ASA) score equal to or up to 3 Unwilling or unable to use patient-controlled analgesia (PCA) Chronic consumption of opioids Chronic drug or alcohol abuse Chronic pain Unable to read or write text Inflammatory disease of intestinal tract Allergy to morphine Allergy to lidocaine Severe atrioventricular conduction dysfunction without stimulator Porphyry Uncontrolled epilepsy History of malign hyperthermia Severe cardiac failure Hepatic failure Myasthenia Treatment with beta blockers, antiarrhythmic calcium blockers, sultopride, nonselective monoamine oxidase inhibitor (MAOI) Locoregional anaesthesia planned Associated surgery concerning liver, pancreas, or gall bladder Laparoscopic surgery Severe psychiatric pathology Refusal of the patient
Sites / Locations
- Hôpital Saint-Antoine